Can you provide a detailed explanation of preventive treatment for migraine?

Preventive Treatment for Migraine: A Detailed Explanation

Preventive therapy should be initiated in patients who remain adversely affected on at least 2 days per month despite optimized acute treatment, though this threshold is not absolute and must account for attack severity, duration, and disability. 1

When to Initiate Preventive Treatment

The decision to start preventive therapy depends on several key factors beyond simple attack frequency:

• ≥2 migraine attacks per month producing disability lasting ≥3 days 2
• Overuse of acute medications (more than twice per week) 1, 2
• Contraindication to or failure of acute treatments 2
• Severe, prolonged attacks that significantly impair quality of life between episodes 1
• Uncommon migraine conditions including hemiplegic migraine, prolonged aura, or migrainous infarction 2

Critical pitfall: The "2 days per month" rule is a practical guideline, not an absolute threshold. Consider preventive therapy for patients with less frequent but severely disabling attacks, especially menstruation-related migraines that tend to last longer 1.

First-Line Preventive Medications

Start with beta-blockers (without intrinsic sympathomimetic activity), topiramate, or candesartan 1:

Beta-Blockers

• Propranolol 80-240 mg/day 2
• Timolol 20-30 mg/day 2
• Atenolol, bisoprolol, or metoprolol 1
• Common side effects: fatigue, depression, nausea, dizziness, insomnia (generally well-tolerated) 2
• Avoid beta-blockers with intrinsic sympathomimetic activity (acebutolol, alprenolol, oxprenolol, pindolol) as they are ineffective 2

Antiseizure Medications

• Topiramate 1, 3
• Divalproex sodium 500-1500 mg/day or sodium valproate 800-1500 mg/day 2
• Valproate is strictly contraindicated in women of childbearing potential due to teratogenic effects (neural tube defects) 1
• Side effects: hair loss, tremor, weight gain 4

Angiotensin Receptor Blockers

• Candesartan 1, 3

Second-Line Preventive Medications

Use flunarizine, amitriptyline, or (in men only) sodium valproate when first-line agents fail 1:

Tricyclic Antidepressants

• Amitriptyline 30-150 mg/day 2
• Particularly effective for patients with mixed migraine and tension-type headache 2
• Side effects: weight gain, drowsiness, anticholinergic symptoms 4

Calcium Channel Blockers

• Flunarizine 10 mg/day (where available) 2, 1
• Side effects: sedation, weight gain, abdominal pain, depression, extrapyramidal symptoms (especially in elderly) 2

Third-Line Preventive Medications

Consider CGRP monoclonal antibodies after failure of multiple oral preventives 1, 3:

• Erenumab, fremanezumab, galcanezumab, eptinezumab 1
• In Europe, regulatory restrictions limit use to patients who have failed other preventive drugs or have contraindications 1
• For chronic migraine specifically: onabotulinumtoxinA 1, 3

Treatment Implementation Strategy

Dosing and Titration

Start with a low dose and titrate slowly upward until clinical benefits appear or side effects limit further increases 2:

• Use once-daily dosing schedules to improve adherence, which is often very poor 1
• Simplified dosing regimens significantly enhance treatment compliance 1

Timeline for Efficacy Assessment

Critical timing considerations (patients must understand these to avoid premature discontinuation):

• Oral preventive medications: Assess after 2-3 months 1
• CGRP monoclonal antibodies: Assess after 3-6 months 1
• OnabotulinumtoxinA: Assess after 6-9 months 1

Efficacy is rarely observed immediately—patients must be discouraged from abandoning treatment in early stages due to apparent inefficacy 1.

Treatment Duration and Discontinuation

After 6-12 months of successful treatment, consider pausing therapy 1:

• The purpose is to determine whether preventive treatment can be stopped, minimizing unnecessary drug exposure 1
• Some patients can manage with acute medications only after successful preventive therapy 1
• Taper doses gradually rather than abrupt cessation 2
• Use a pragmatic, case-by-case approach for discontinuation decisions 1

Measuring Success

Calculate the percentage reduction in monthly migraine days or monthly headache days of moderate-to-severe intensity 1. This quantifiable measure helps determine treatment efficacy objectively.

Managing Treatment Failure

Failure of one preventive treatment does not predict failure of other drug classes (except when due to poor adherence) 1:

• If one medication fails after adequate trial, switch to a different drug class 1
• Before declaring treatment failure, verify:
  • Adequate dosing was achieved
  • Sufficient trial duration (2-3 months minimum for oral agents)
  • No overuse of acute medications (which can undermine preventive efficacy) 2
  • Good adherence to the regimen 1

Non-Pharmacological Preventive Options

Consider as adjuncts to medication or as stand-alone treatment when medication is contraindicated 1:

• Neuromodulatory devices (evidence supports use) 1
• Biobehavioral therapy including biofeedback, cognitive-behavioral therapy, relaxation therapy 1, 5
• Acupuncture (though not superior to sham acupuncture in some studies) 1

Limited or no evidence exists for: physical therapy, spinal manipulation, dietary approaches 1

Nutraceuticals with Fair Evidence

• Magnesium citrate 2, 5
• Riboflavin 2, 5
• Coenzyme Q10 5

These have modest efficacy but limited use in clinical practice due to inconsistent evidence 1.

Special Considerations

Medication Selection Strategy

Choose preventive medication based on:

1. Contraindications (check first) 2
2. Comorbid conditions that might benefit from specific agents:
   • Hypertension → beta-blockers 2
   • Mixed migraine/tension-type headache or depression → amitriptyline 2
   • Prolonged or atypical aura → valproate 4
3. Side effect profile relative to patient concerns:
   • Weight gain concerns → avoid flunarizine, amitriptyline, valproate 2, 4
   • Athletes → avoid beta-blockers 6
4. Drug interactions with acute medications 2
5. Patient preference and cost 2

Avoiding Medication Overuse Headache

A key indication for preventive therapy is overuse of acute medications 1. Once preventive treatment begins, avoid interfering medications such as overused acute treatments (especially ergotamine) 2. This creates a vicious cycle that undermines preventive efficacy.

Monotherapy vs. Combination

Most cases should use monotherapy—try successive drugs from different classes before combining agents 6. This approach clarifies which medication provides benefit and minimizes polypharmacy risks.